Cargando…
Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy
Semicarbazide-sensitive amine oxidase (SSAO) is an enzyme with a unique dual function in controlling inflammation as well as reactive oxygen species (ROS) generation. We have demonstrated benefit of SSAO inhibition in acute kidney fibrosis. However the function of SSAO in chronic kidney disease (CKD...
Autores principales: | Wong, May YW, Saad, Sonia, Wong, Muh Geot, Stangenberg, Stefanie, Jarolimek, Wolfgang, Schilter, Heidi, Zaky, Amgad, Gill, Anthony, Pollock, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302447/ https://www.ncbi.nlm.nih.gov/pubmed/32555665 http://dx.doi.org/10.1371/journal.pone.0234617 |
Ejemplares similares
-
Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
por: Stangenberg, Stefanie, et al.
Publicado: (2018) -
Serum level of semicarbazide-sensitive amine oxidase in children with ADHD
por: Roessner, Veit, et al.
Publicado: (2006) -
FXR expression is associated with dysregulated glucose and lipid levels in the offspring kidney induced by maternal obesity
por: Glastras, Sarah J., et al.
Publicado: (2015) -
Activity of semicarbazide-sensitive amine oxidase in guinea-pig tissues is not affected by metformin
por: Lukan, Katja, et al.
Publicado: (2012) -
Effects of semicarbazide-sensitive amine oxidase inhibitors on morphology of aorta and kidney in diabetic rats
por: Li, Chaosheng, et al.
Publicado: (2019)